Расширенный поиск

Возможности достижения стабильного контроля бронхиальной астмы с учетом вариабельности заболевания

Полный текст:


Возможности достижения стабильного контроля бронхиальной астмы с учетом вариабельности заболевания.

Об авторе

Н. М. Ненашева
ГОУ ДПО "Российская медицинская академия последипломного образования"

д. м. н, проф. кафедры клинической аллергологии 

123995, Москва, ул. Баррикадная, 2 / 1. Тел.: +7-499-196-19-54.

Список литературы

1. Rosi E., Ronchi M.C., Grazzini M. et al. Sputum analysis, bronchial hyperresponsiveness and airway function in asthma: results of a factor analysis. J. Allergy Clin. Immunol. 1999; 103: 232–237.

2. Reddel H.K., Taylor R., Bateman E.D. et al. An official American Thoracic Society / European Respiratory Society Statement: Asthma control and exacerbations. Am. J. Respir. Crit. Care Med. 2009; 180: 59–99.

3. GINA 2009. Available from:

4. Sullivan S.D., Wenzel S.E., Bresnahan B.W. et al. TENOR study Group. Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients. Allergy 2007; 62: 655–660.

5. Thomas M., Kay S., Pike J. et al. The Asthma Control Test TM (ACT) as a predictor of asthma guidelines-specified control: Analysis of a multinational cross-sectional survey. Prim. Care Respir. J. Prim. 2009; 18 (1): 41–49.

6. Schatz M., Sorkness C.A., Li J.T. et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J. Allergy Clin. Immunol. 2006; 117: 549–556.

7. Schatz M., Kosinski M., Yarlas A. et al. The Minimally Important Difference (MID) of the Asthma Control Test (ACT) administered by telephone. J. Allergy Clin. Immunol. 2009; 124 (4): 719–723.

8. Chipps B.E., Spahn J.D. What are the determinates of asthma control? J. Asthma 2006; 43: 567–572.

9. Wenzel S.E. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368: 804–813.

10. Szefler S.J., Phillips B.R., Martinez F.D. et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J. Allergy Clin. Immunol. 2005; 115 (2): 233–242.

11. Asthma variability in patients previously treated with β2-agonists alone. J. Allergy Clin. Immunol. 2003; 112: 1088–1094.

12. Silverman R.A., Stevenson L., Hastings H.M. Age-related seasonal patterns of emergency department visits for acute asthma in an urban environment. Ann. Emerg. Med. 2003; 42: 577–586.

13. Weiss K.B. Seasonal trends in US asthma hospitalizations and mortality. J. A. M. A. 1990; 263 (17): 2323–2328.

14. Ritz T., Kullowatz A., Kanniess F. et al. Perceived triggers of asthma: evaluation of a german version of the asthma trigger inventory. Respir. Med. 2008; 102: 390–398.

15. Bateman E.D., Boushey H.A., Bousquet J. et al. Can guideline-defined asthma control be achieved? Am. J. Respir. Crit. Care Med. 2004; 170: 836–844.

16. Bateman E.D., Bousquet J., Busse W.W. et al. Stability of asthma control with regular treatment: an analysis of GOAL study. Allergy 2008; 63: 932–938.

17. Bateman E.D., Bousquet J., Keech M.L. et al. The correlation between asthma control and health status: the GOAL study. Eur. Respir. J. 2007; 29: 56–63.

Для цитирования:

Ненашева Н.М. Возможности достижения стабильного контроля бронхиальной астмы с учетом вариабельности заболевания. Пульмонология. 2011;(3):119-122.

For citation:

Nenasheva N.M. Abilities to achieve stable control of asthma with regard to variability of the disease. PULMONOLOGIYA. 2011;(3):119-122. (In Russ.)

Просмотров: 222

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)